Effects of Pharmacological Treatment for Neonatal Abstinence Syndrome on DNA Methylation and Neurobehavior: A Prospective Cohort Study
To determine whether pharmacological treatment for neonatal abstinence syndrome (NAS) is associated with changes in DNA methylation (DNAm) of the mu-opioid receptor gene (OPRM1) and improvements in neonatal neurobehavior.
source https://www.jpeds.com/article/S0022-3476(21)01264-6/fulltext?rss=yes
source https://www.jpeds.com/article/S0022-3476(21)01264-6/fulltext?rss=yes
Comments
Post a Comment